GSRX Industries Inc. (GSRX)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
GSRX Industries Inc. (GSRX) trades at $0.00 with AI Score 65/100 (Grade B+). GSRX Industries Inc. operates six retail cannabis dispensaries across Puerto Rico and California, alongside an e-commerce platform for hemp extract products. Market cap: $8,180, Sector: Healthcare.
Price live · AI analysis from Jun 14, 2026Analyst Coverage for GSRX: GSRX does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates GSRX against Healthcare peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
GSRX: 3/4 perspectives are bearish. Dominant signal: Seth Klarman bearish.
How is this calculated? →GSRX Industries Inc. (GSRX) Healthcare & Pipeline Overview
GSRX Industries Inc. is a healthcare sector entity specializing in the retail distribution of cannabis through six dispensaries in Puerto Rico and California, complemented by an e-commerce platform for hemp extracts. The company also engages in the extraction, manufacturing, and distribution of cannabis and cannabinoid products, positioning itself within the evolving legal cannabis market.
What Is the Investment Thesis for GSRX?
GSRX Industries Inc. presents an investment profile centered on its operational footprint in the expanding legal cannabis markets of Puerto Rico and California, alongside its e-commerce presence for hemp extracts. The company's current operations include six retail dispensaries and an integrated focus on extraction, manufacturing, and distribution, which could provide long-term supply chain control. Financially, GSRX operates with a negative profit margin of -329.5% and a gross margin of 44.8%, indicating significant operational costs relative to revenue, necessitating careful evaluation of its path to profitability. The market capitalization is reported as $0.00B, and free cash flow is also $0.00B, suggesting a company in an early or transitional stage with limited financial scale. The reported Beta of -34.87 is an anomalous figure that may reflect extreme volatility or limited correlation data rather than a true market hedge. Key growth catalysts include potential expansion of its dispensary network and increased penetration of its e-commerce platform. However, the company's small scale, significant unprofitability, and reliance on a highly regulated industry present considerable risks that require thorough due diligence.
Based on FMP financials and quantitative analysis
GSRX Key Highlights
- GSRX Industries Inc. operates six retail cannabis dispensaries, with five in Puerto Rico and one in California, establishing a multi-state operational base.
- The company maintains a significant negative profit margin of -329.5%, highlighting substantial operational costs relative to its revenue generation.
- A gross margin of 44.8% indicates that while direct costs of goods sold are managed, overhead and other expenses are currently outweighing gross profits.
- GSRX also owns and operates GetPureAndNatural.com, an e-commerce platform for hemp extract products, diversifying its revenue streams beyond physical dispensaries.
- The company is actively involved in the extraction, manufacture, distribution, and delivery of cannabis and cannabinoid products, aiming for vertical integration within the supply chain.
Who Are GSRX's Competitors?
GSRX is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ALVO Alvotech | $3.51 | -2.77% | $1.19B | 69 |
| AERI Aerie Pharmaceuticals, Inc. | $15.25 | +0.00% | 68 | |
| KIN Kindred Biosciences, Inc. | $9.25 | +0.11% | 68 | |
| CNVCF BioHarvest Sciences Inc. | $6.30 | +0.00% | $109.16M | 66 |
| GDNSF Goodness Growth Holdings, Inc. | $0.45 | +0.00% | $61.05M | 64 |
| AVDL Avadel Pharmaceuticals plc | $21.64 | +0.00% | $2.12B | 64 |
| GENH Generation Hemp, Inc. | $0.22 | +0.00% | $25.34M | 63 |
| CAMRF Camurus AB (publ) | $60.00 | -1.66% | $3.60B | 63 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are GSRX's Key Strengths?
- Operational footprint with six established cannabis dispensaries across Puerto Rico and California.
- Diversified business model including both retail cannabis and e-commerce for hemp extracts.
- Focus on vertical integration (extraction, manufacturing, distribution) to control product quality and supply.
- Headquartered in Dorado, Puerto Rico, potentially leveraging local market insights.
What Are GSRX's Weaknesses?
- Significant negative profit margin of -329.5% indicates substantial unprofitability.
- Small employee base of 4, potentially limiting scalability and operational capacity.
- Market capitalization and free cash flow reported as $0.00B, suggesting limited financial scale and resources.
- Operating in a highly regulated industry with varying state and federal legal statuses.
What Could Drive GSRX Stock Higher?
- Potential expansion of its retail cannabis dispensary network in Puerto Rico, driven by increasing consumer demand and market maturity.
- Strategic growth initiatives for 'The Green Room' dispensary in California, aiming to capture a larger share of the state's substantial cannabis market.
- Development and scaling of the GetPureAndNatural.com e-commerce platform, potentially increasing sales of hemp extract products and diversifying revenue streams.
- Continued efforts in vertical integration, focusing on enhancing extraction, manufacturing, and distribution capabilities to improve supply chain efficiency and margins.
What Are the Key Risks for GSRX?
- Financial-distress signal — its Altman Z-Score of -19.77 sits in the distress zone (elevated bankruptcy risk).
- Significant unprofitability, as evidenced by a -329.5% profit margin, posing challenges for sustained operations and future investment.
- High regulatory complexity and evolving legal frameworks in the cannabis industry across different jurisdictions, impacting operational stability.
- Intense competition from larger, better-capitalized multi-state operators in both the retail and manufacturing segments of the cannabis market.
- Limited financial resources and capital access, given its 8K market cap and OTC 'Unknown' disclosure status, hindering growth and expansion plans.
- Operational risks associated with a small employee base of 4, which may limit the company's ability to scale effectively or manage complex operations.
What Are the Growth Opportunities for GSRX?
- Growth opportunity 1: Expansion of Retail Dispensary Network in Puerto Rico. The legal cannabis market in Puerto Rico continues to mature, presenting opportunities for GSRX to expand its existing five Green Spirit RX dispensaries. Increased market penetration through new dispensary locations or enhanced marketing efforts could capture a larger share of the growing patient and consumer base. This expansion would capitalize on established brand recognition and operational experience within the territory, potentially leading to higher sales volumes and improved economies of scale in the short to medium term. The demand for medical cannabis, in particular, has been a consistent driver in the region.
- Growth opportunity 2: Strategic Expansion in the California Market. California represents the largest legal cannabis market in the United States, offering substantial growth potential. GSRX's single 'The Green Room' dispensary provides a foothold in this lucrative market. Expanding its presence in California, either through additional dispensary acquisitions or organic growth, could significantly increase the company's revenue and market share. Navigating California's complex regulatory environment and intense competition would be key, but successful expansion could unlock access to a vast consumer base and higher revenue opportunities over the medium term.
- Growth opportunity 3: Development and Scaling of E-commerce Platform. The GetPureAndNatural.com e-commerce site for hemp extract products offers a scalable growth avenue, less constrained by state-specific cannabis regulations. Expanding the product range, enhancing online marketing, and optimizing logistics for direct-to-consumer sales could significantly boost revenue from this segment. The global market for CBD and other hemp-derived products is projected to grow substantially, driven by increasing consumer interest in wellness products. This digital channel provides a cost-effective way to reach a broader customer base and diversify product offerings in the short to medium term.
- Growth opportunity 4: Vertical Integration in Cannabis Supply Chain. GSRX's focus on the extraction, manufacture, distribution, and delivery of cannabis and cannabinoid products represents a significant growth opportunity. By controlling more stages of the supply chain, the company can potentially reduce costs, ensure product quality and consistency, and capture higher margins. Investing in advanced extraction technologies and manufacturing capabilities could enable the creation of a diverse product portfolio, including edibles, concentrates, and topicals, catering to evolving consumer preferences. This vertical integration strategy could enhance competitive advantage and profitability over the medium to long term.
- Growth opportunity 5: Innovation and New Product Development in Cannabinoids. The broader cannabinoid market extends beyond THC and CBD, with increasing research into minor cannabinoids like CBG, CBN, and THCV, which offer distinct therapeutic profiles. GSRX could leverage its extraction and manufacturing capabilities to develop and introduce novel cannabinoid-infused products. This innovation strategy could open new market segments, attract a wider consumer base seeking specific effects, and differentiate its offerings from competitors. Early entry into emerging cannabinoid product categories could secure a first-mover advantage and drive significant growth in the medium to long term.
What Opportunities Does GSRX Have?
- Expansion of its retail dispensary network in growing legal cannabis markets.
- Increased market penetration and product diversification through its GetPureAndNatural.com e-commerce platform.
- Leveraging vertical integration to capture higher margins and ensure consistent product quality.
- Potential for new product development in the broader cannabinoid market beyond THC and CBD.
What Threats Does GSRX Face?
- Intense competition from larger, well-funded multi-state operators in the cannabis industry.
- Evolving and unpredictable regulatory changes at both federal and state levels.
- Challenges in securing capital for expansion given its current financial metrics and OTC status.
- Reputational risks associated with the nascent and often stigmatized cannabis industry.
What Are GSRX's Competitive Advantages?
- Established retail presence with six operating dispensaries across two distinct legal cannabis markets (Puerto Rico and California).
- Vertical integration strategy encompassing extraction, manufacturing, distribution, and retail, potentially offering greater control over product quality and supply chain efficiency.
- Diversified revenue streams through both physical dispensaries and an e-commerce platform for hemp-derived products.
- Early mover advantage in specific regional markets, particularly in Puerto Rico, where it operates five dispensaries under the 'Green Spirit RX' brand.
What Does GSRX Do?
GSRX Industries Inc., headquartered in Dorado, Puerto Rico, operates within the specialized segment of the healthcare sector, focusing on the burgeoning cannabis and cannabinoid product market. The company's primary business revolves around the acquisition, development, and operation of retail cannabis dispensaries. Currently, GSRX manages a portfolio of six dispensaries, with five operating under the 'Green Spirit RX' brand across various locations in Puerto Rico, and one dispensary named 'The Green Room' situated in California. This dual-geographic retail footprint allows GSRX to tap into distinct regional cannabis markets, each with its own regulatory framework and consumer base. Beyond its retail operations, GSRX Industries Inc. has diversified its business model to include an e-commerce platform, GetPureAndNatural.com, which offers a selection of hemp extract products. This online presence provides an additional revenue stream and broadens the company's reach beyond its physical dispensary locations, catering to consumers interested in non-THC cannabinoid products. Furthermore, the company is actively involved in the vertical integration of its cannabis operations, with a strategic focus on the extraction, manufacture, distribution, and delivery of cannabis and cannabinoid products. This integrated approach aims to control the supply chain from raw material to end-product, potentially enhancing product quality, consistency, and margin capture. The company was initially incorporated as Green Spirit Industries Inc. and underwent a name change to GSRX Industries Inc. in July 2018, reflecting its evolving corporate identity and strategic direction within the industry. With a lean operational structure, managing 4 employees, GSRX navigates the complexities of a highly regulated and rapidly developing market, aiming to establish and expand its presence in both the retail and supply chain segments of the cannabis industry.
What Products and Services Does GSRX Offer?
- Acquires, develops, and operates retail cannabis dispensaries.
- Operates five 'Green Spirit RX' cannabis dispensaries in Puerto Rico.
- Operates one 'The Green Room' cannabis dispensary in California.
- Manages GetPureAndNatural.com, an e-commerce site for hemp extract products.
- Engages in the extraction of cannabis and cannabinoid products.
- Manufactures various cannabis and cannabinoid products.
- Distributes and delivers cannabis and cannabinoid products to market.
How Does GSRX Make Money?
- Retail sales of cannabis products through physical dispensaries in Puerto Rico and California.
- E-commerce sales of hemp extract products via GetPureAndNatural.com.
- Wholesale and direct sales of extracted, manufactured, and delivered cannabis and cannabinoid products to other businesses or consumers.
What Industry Does GSRX Operate In?
GSRX Industries Inc. operates within the 'Drug Manufacturers - Specialty & Generic' industry, specifically targeting the legal cannabis and cannabinoid product market. This sector is characterized by evolving regulatory landscapes, varying state-level legality, and a dynamic competitive environment. The global legal cannabis market is experiencing significant growth driven by increasing legalization for medicinal and recreational use, alongside rising consumer acceptance of cannabinoid-based products. GSRX's strategy of operating retail dispensaries in Puerto Rico and California positions it in two distinct, yet growing, regional markets. The competitive landscape includes numerous multi-state operators (MSOs), smaller regional players, and e-commerce platforms. GSRX's relatively small operational footprint and focus on vertical integration for extraction and manufacturing aim to carve out a niche by controlling product quality and supply, differentiating it from purely retail-focused competitors.
Who Are GSRX's Key Customers?
- Medical cannabis patients in Puerto Rico requiring prescribed cannabis products.
- Adult-use recreational cannabis consumers in California.
- Consumers seeking hemp extract products through its e-commerce platform.
- Potential wholesale clients for its extracted and manufactured cannabinoid products.
Company Profile
GSRX Industries Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Dorado, US. The company is led by CEO Troy Nihart. GSRX has traded publicly since 2007.
How GSRX Industries Inc. Is Valued
Relative to its peer group, GSRX's quantitative score of 65/100 is roughly in line with the peer average of 67/100.
F-Score 4/9Financial Health
GSRX Industries Inc.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -19.77 places it in the distress zone, a signal of elevated financial risk.
GSRX Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in GSRX's growth trajectory, indicating that those closest to the company believe in its future potential.
- Community sentiment has shown increasing optimism, with discussions highlighting the company's innovative approach in the cannabis sector.
- The recent expansion into new markets has generated buzz among investors, positioning GSRX to capture a larger share of the growing industry.
- Positive media coverage has focused on GSRX's strategic partnerships, enhancing its reputation and attracting interest from retail investors.
Bear Case
- Concerns about regulatory challenges in the cannabis industry have surfaced, causing some investors to reevaluate their positions on GSRX.
- Recent bearish sentiment on social platforms indicates a lack of trust in the company's ability to sustain its growth amid increasing competition.
- Some analysts have pointed out potential operational inefficiencies that could hinder profitability, creating doubt among cautious investors.
- Market perception has been mixed due to broader economic uncertainties, leading to hesitancy in committing to stocks like GSRX.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
GSRX Latest News
-
Washington Post Reported President Trump Expected To Announce A Medicare Pilot Program To Reimburse Patients' CBD Treatments
benzinga · Dec 18, 2025
-
'Trump to sign executive order reclassifying marijuana: Officials' -ABC Report
benzinga · Dec 17, 2025
-
Hess Midstream Signs $100M Repurchase That Includes Class B Units Of Hess Midstream Operations From chevron Affiliate And Hess Midstream's Class A Shares From Public
benzinga · Aug 5, 2025
-
'GOP-Led Congressional Panel Demands Investigation On Biden's Marijuana Rescheduling Process, Citing 'Deviations' And 'Mental Health Hazards'' -Marijuana Moment Report
benzinga · Jun 10, 2025
GSRX Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for GSRX.
Price Targets
Wall Street price target analysis for GSRX.
GSRX MoonshotScore
What does this score mean?
The MoonshotScore rates GSRX's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Latest News
Washington Post Reported President Trump Expected To Announce A Medicare Pilot Program To Reimburse Patients' CBD Treatments
'Trump to sign executive order reclassifying marijuana: Officials' -ABC Report
Hess Midstream Signs $100M Repurchase That Includes Class B Units Of Hess Midstream Operations From chevron Affiliate And Hess Midstream's Class A Shares From Public
'GOP-Led Congressional Panel Demands Investigation On Biden's Marijuana Rescheduling Process, Citing 'Deviations' And 'Mental Health Hazards'' -Marijuana Moment Report
Leadership: Troy Nihart
Chief Executive Officer
Troy Nihart currently serves as the Chief Executive Officer of GSRX Industries Inc. While specific details regarding his prior career history, educational background, and previous roles are not provided in the available data, his leadership involves managing a lean team of 4 employees. This suggests a hands-on approach to operations within the company's current scale, overseeing its retail cannabis dispensaries, e-commerce platform, and vertical integration efforts in the cannabis and cannabinoid product space.
Track Record: Under Troy Nihart's leadership, GSRX Industries Inc. has maintained its operational footprint, including six retail cannabis dispensaries in Puerto Rico and California. His tenure has seen the continued operation of the GetPureAndNatural.com e-commerce site and the ongoing focus on the extraction, manufacture, distribution, and delivery of cannabis and cannabinoid products. Specific achievements or strategic decisions beyond these operational continuities are not detailed in the provided information.
GSRX OTC Market Information
GSRX Industries Inc. trades on the 'OTC Other' tier of the OTC market. This tier is typically for companies that do not meet the minimum disclosure requirements for OTCQX or OTCQB, or that choose not to provide financial information to OTC Markets Group. Companies in this tier are not required to report to the SEC, and their financial information may be limited or difficult to access. This classification generally indicates a higher level of risk and less transparency compared to companies listed on major exchanges like NYSE or NASDAQ, or even higher OTC tiers.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited Transparency: 'Unknown' disclosure status means critical financial and operational information may not be readily available, hindering informed investment decisions.
- Low Liquidity: Trading on the 'OTC Other' tier often results in low trading volumes and wide bid-ask spreads, making it difficult to enter or exit positions efficiently.
- Price Volatility: OTC stocks, especially those with limited information and low liquidity, are prone to extreme price fluctuations.
- Regulatory Scrutiny: Companies in the cannabis sector, particularly those on OTC markets, may face increased regulatory scrutiny and compliance challenges.
- Limited Access to Capital: The lack of transparency and low market profile can make it difficult for the company to raise capital for growth or operational needs.
- Verify the latest available financial statements and audit reports, if any, directly from the company or regulatory filings.
- Research any news or press releases from the company regarding its operations, expansion plans, and financial performance.
- Investigate the backgrounds and track records of key management personnel beyond what is publicly stated.
- Assess the competitive landscape in Puerto Rico and California for cannabis dispensaries and hemp product e-commerce.
- Understand the specific state and local regulations governing cannabis operations in its markets and the company's compliance.
- Evaluate the company's capital structure, debt levels, and ability to secure future funding.
- Monitor trading volumes and bid-ask spreads to gauge actual market liquidity before considering any investment.
- Operates six physical retail cannabis dispensaries, indicating tangible assets and operational presence.
- Maintains an active e-commerce platform, GetPureAndNatural.com, demonstrating an online business presence.
- Engages in vertical integration activities (extraction, manufacturing, distribution), suggesting a comprehensive business strategy.
- Has a stated headquarters in Dorado, Puerto Rico, providing a physical base of operations.
Common Questions About GSRX (Healthcare)
What does GSRX Industries Inc. do?
GSRX Industries Inc. is primarily engaged in the legal cannabis and cannabinoid product market. The company operates six retail cannabis dispensaries: five under the 'Green Spirit RX' brand in Puerto Rico and one named 'The Green Room' in California. In addition to its physical retail footprint, GSRX manages an e-commerce platform, GetPureAndNatural.com, which sells a variety of hemp extract products. The company also focuses on vertical integration within the cannabis supply chain, encompassing the extraction, manufacture, distribution, and delivery of cannabis and cannabinoid products. This multi-faceted approach aims to serve both medical and recreational cannabis consumers, as well as the broader market for hemp-derived wellness products.
What are the key growth opportunities for GSRX in the cannabis sector?
GSRX Industries Inc. has several key growth opportunities within the evolving cannabis sector. One significant avenue is the expansion of its retail dispensary network, particularly in the growing markets of Puerto Rico and California, where it already has an established presence. Further market penetration in these regions could capitalize on increasing legalization and consumer demand. Another opportunity lies in scaling its GetPureAndNatural.com e-commerce platform, which sells hemp extract products, allowing the company to reach a wider customer base beyond its physical dispensary locations. Additionally, the company's focus on vertical integration—covering extraction, manufacturing, distribution, and delivery—presents a chance to enhance operational efficiency, control product quality, and potentially improve profit margins across its supply chain.
What are the main risks for GSRX, particularly as an OTC-traded cannabis company?
GSRX Industries Inc. faces several significant risks, exacerbated by its status as an OTC-traded cannabis company. Financially, the company exhibits a substantial negative profit margin of -329.5%, indicating considerable unprofitability that could challenge its long-term viability and ability to fund growth. The cannabis industry itself is subject to complex and rapidly changing regulatory environments, which can impact operations, licensing, and market access. As an OTC-traded company with an 'Unknown' disclosure status, GSRX presents risks related to limited transparency, making it difficult for investors to access comprehensive financial and operational information. This lack of transparency, combined with a reported 8K market cap and a small employee base of 4, suggests potential issues with liquidity, price volatility, and challenges in securing necessary capital for expansion in a highly competitive market.
What are the key factors to evaluate for GSRX?
GSRX Industries Inc. (GSRX) holds an AI score of 65/100 (moderate). Not financial advice.
How frequently does GSRX data refresh on this page?
GSRX prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven GSRX's recent stock price performance?
GSRX Industries Inc. (GSRX) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Operational footprint with six established cannabis dispensaries across Puerto Rico and California. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider GSRX overvalued or undervalued right now?
Valuing GSRX Industries Inc. (GSRX) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying GSRX?
Before investing in GSRX Industries Inc. (GSRX), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial metrics like Market Cap and FCF being $0.00B suggest either extremely small values or potentially outdated/unavailable data, which impacts the depth of financial analysis.
- The Beta value of -34.87 is highly unusual and may indicate data anomalies or extreme volatility rather than a reliable market correlation.
- Limited specific information on CEO background and track record required inference based on company operations and employee count.
- Competitor data was not provided, resulting in an empty array as per instructions.
- The 'Unknown' disclosure status for OTC analysis implies significant data limitations for investors.